Yi-Hsing Chen,Wan-Hua Tsai,Ya-Hui Chen,Chih-Ho Lai,Yu-Hsin Lin
申请号：
US16129029
公开号：
US10638784B2
申请日:
2018.09.12
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention provides a pharmaceutical composition and a food product for inhibiting gastritis induced by gastric Helicobacter pylori, comprising Lactobacillus selected from a group composed of Lactobacillus rhamnosus GM-020 (also known as GMNL-74) with deposited number CCTCC M203098； Lactobacillus acidophilus GMNL-185 with deposited number CCTCC M2017764； and Lactobacillus plantarum GMNL-662 with deposited number CCTCC M2016571； and any two of the above bacteria.
